
About Restech
Restech is a Healthcare company based in Houston (United States) founded in 2003 by Jeff Schipper. Provider of patient health diagnosis and treatment management devices for providers. Restech has raised $304.98 thousand across 1 funding round. Restech has completed 1 acquisition, including Mederi Therapeutics. Its focus areas include HealthTech, Healthcare IT, Provider and Clinical Operations. Its competitors include QuidelOrtho, ProciseDx and WuXi Diagnostics; 2 of its 3 listed competitors have raised funding.
Company details
Medical devices for patient health diagnosis and treatment management are supplied by Restech to healthcare providers. Founded in 2003 and based in Houston, United States, the company focuses on gastrointestinal sector operations. Devices are designed to aid physicians in identifying refluxes and fecal abnormalities, with capabilities for displaying warnings and analyzing therapeutic pathways included.
- Headquarters Houston, United States
- Founders Jeff Schipper
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website restech.com
- Social LinkedIn X Facebook
- Total Equity Funding$304.98K (USD)
in 1 rounds
- Latest Funding Round$304.98K (USD), Seed
Nov 2023
- Investments & Acquisitions
Funding Insights of Restech
Restech has successfully raised a total of $304.98K through 1 strategic funding round. The most recent funding activity was a Seed round of $304.98 thousand completed in November 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $304,975
- Total Rounds 1
- Last Round Seed β $304,975
- First Round $304,975
(Nov 2023)
All 1 funding rounds of Restech with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2023 | $304,975 | Seed | β | β | β |
People of Restech
7 people are tracked at Restech (3 in leadership, 4 in team).
| Name | Role | Group |
|---|---|---|
Jeff Schipper | Co-Founder | Leadership |
Leo Roucher | President & CEO | Leadership |
Brandon Wang | Director Of Finance | Leadership |
Lauren Fisk | Regional Manager, Western Division | Team |
Dan Huff | Sales Representative | Team |
Remigio Jalomo (Ray) | Warehouse Manager | Team |
Jehad Nsir | Sales | Team |
Complete people profiles for Restech
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Restech
Restech has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Mederi Therapeutics.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Minimally invasive RF devices for gastrointestinal diseases are developed. | mederi-inc.com | Greenwich, United States | 2008 | Apr 2018 | β’β’β’β’ |
Complete acquisition details for Restech
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Restech
3 dated milestones of Restech across 20 years, from founding to its latest funding, stage changes and deals.
- Founded Restech is founded.
- Acquisition Acquires Mederi Therapeutics.
- Funding First funding round of $305K.
Competitors of Restech
Restech has 3 listed competitors in our database, 2 of them funded. They include QuidelOrtho, ProciseDx and WuXi Diagnostics.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| quidelortho.com | 1937 | San Diego, United States | 278 | Provider of healthcare information services | ||
| procisedx.com | 2018 | San Diego, United States | $8.96M | Point-of-care diagnostic devices for immunoassay tests are provided to clinicians. | ||
| wuxidiagnostics.com | 2018 | Rochester, United States | $200M | Diagnostic solutions for disease identification are offered to healthcare providers. |
Detailed competitors of Restech
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Restech
Websites that share an audience with Restech (restech.com).
Websites whose visitors overlap most with Restech. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| vitas.com | 100% | 213K | #191,178 | View details | |
| alfascientific.com | 100% | #8,547,751 | View details | ||
clinicalfoundations.org | clinicalfoundations.org | 100% | β | ||
| truvianhealth.com | 99% | 4.2K | #4,492,336 | View details | |
| sekisuidiagnostics.com | 98% | #2,255,959 | View details | ||
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 40 similar websites and full traffic analytics for Restech
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Clinical IT & Data Platforms
3 companies that operate in the same segment as Restech (Clinical IT & Data Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Employee health benefits are facilitated via a cloud-based platform. | 2007 | Plymouth Meeting, Pennsylvania, United States | USD 228.3 M | |||
Healthcare appointments are booked online via Zocdoc's platform. | 2007 | New York, New York, United States | USD 425.97 M | USD 4.66 M | 1,365 | |
Virtual physical therapy and digital pain care solutions are provided. | 2015 | San Francisco, California, United States | USD 854.44 M | 1,746 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Restech
Restech was founded in 2003 and raised its 1st funding round 20 years after it was founded.
Restech is headquartered in Houston, United States. It is registered at Houston, Texas, United States.
Restech is a funded company, having raised a total of $304.98K across 1 funding round to date. The company's 1st funding round was a Seed of $304.98K, raised on Nov 2023.
Medical devices for patient health diagnosis and treatment management are supplied by Restech to healthcare providers. Founded in 2003 and based in Houston, United States, the company focuses on gastrointestinal sector operations. Devices are designed to aid physicians in identifying refluxes and fecal abnormalities, with capabilities for displaying warnings and analyzing therapeutic pathways included.
Restech's top competitors include QuidelOrtho, ProciseDx and WuXi Diagnostics.
Restech has made 1 acquisition, including Mederi Therapeutics.